Cell and Gene Manufacturing and Logistics
-
Streamline Mass Photometry Measurement Workflows With MassFerence P2
4/25/2024
Explore a reliable tool for mass photometry calibrations that offers maximum precision with minimum hassle.
-
Mass Photometry In GMP-Regulated Environments For Characterization Of AAV
4/25/2024
Learn about tools to optimize your process when characterizing Adeno-associated virus (AAV) samples in GMP-regulated environments.
-
A New Tool For Rapid Analysis Of Large Viral Vectors
4/25/2024
Optimize your viral vector characterization with an instrument that features a semiautomatic workflow, enabling you to analyze samples of adenovirus and lentivirus within minutes.
-
Benchtop Macro Mass Photometer: KaritroMP
4/25/2024
The new KaritroMP is a benchtop instrument that characterizes large viral vectors. Ideal for informing process development in preclinical settings and early drug development, it analyzes samples of adenovirus vectors (AdV) and lentivirus vectors (LVV) in just minutes. The instrument offers essential vector analysis capabilities, including the assessment of sample purity and stability.
-
Bringing CGTs To Middle Income, Developing Countries
4/25/2024
In this segment from the Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site, panelists take an optimistic look at the future promise of bringing CGTs to patients.
-
Intermediate Storage For Cell Therapies
4/25/2024
This segment from the Cell & Gene Live digital event explores intermediate storage options for cell therapy products and the factors to consider when working with these vendors.
-
The Importance Of Mock Runs, Testing Your Processes
4/25/2024
Panelists in this Cell & Gene Live digital event discuss the importance of performing mock runs to pressure test your processes and operations before sending out a commercial product.
-
Selecting The Right Vendors When Building Your Supply Chain
4/25/2024
What factors should you consider when looking for supply chain vendors?
-
Are There Genetic Risks To Patients When Using Pooled Donor Manufacturing?
4/25/2024
This segment from the Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site, delves into the potential risk to patients when transplanting pooled allogeneic stem cells.
-
The Challenges With Shipping Cell Therapy Products
4/25/2024
In this Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site segment, panelists share some of the worst-case shipping scenarios they’ve encountered when transporting cellular products.